Search results for "Dali"

showing 10 items of 1372 documents

Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy.

2022

Abstract Background Adalimumab is used to treat ulcerative colitis, but additional effectiveness and safety data are needed. Patients and methods This retrospective study considered adults with ulcerative colitis treated with adalimumab at 19 hospitals. Clinical data were collected from the start of treatment, after 2, 6 and 12 months, and at the last visit. Outcome measures of effectiveness were treatment duration, reasons for discontinuation and colectomy. Results We studied 381 patients treated with adalimumab for a median of 12.1 months. Disease activity at the start of treatment was moderate to severe in 262 cases (68.8%) and endoscopic activity was moderate to severe in 339 cases (89.…

musculoskeletal diseasesAdultMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentEffectivenessYoung AdultInternal medicineAdalimumabMedicineHumansAdverse effectskin and connective tissue diseasesColectomyColectomyAgedRetrospective StudiesReal-world evidenceHepatologybusiness.industryGastroenterologyEffectiveneAdalimumabRetrospective cohort studyInduction ChemotherapyMiddle Agedmedicine.diseaseUlcerative colitisDiscontinuationClinical PracticeTreatment OutcomeUlcerative colitisItalyAdalimumab; Effectiveness; Real-world evidence; Safety; Ulcerative colitisConcomitantColitis UlcerativeFemaleTumor Necrosis Factor InhibitorsSafetybusinessmedicine.drugDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Assessing Single Joints in Arthritis Clinical Trials

2009

The need to develop validated outcome measures to assess response to therapies in single joints has been recognized. In 2004, a task force was established to assess established and novel outcome measures in accordance with the OMERACT filter (truth, discrimination, and feasibility) for single joint assessment. This report describes the proceedings of the single joint assessment special interest group (SIG) at OMERACT 9, including an updated literature review of imaging of the knee joints, with a focus on the extent to which these modalities fulfill the OMERACT filter. A series of studies are reported that examine patient reported, clinical examination, and imaging outcomes in therapeutic st…

musculoskeletal diseasesKnee arthritismedicine.medical_specialtyKnee JointImmunologyPsychological interventionPhysical examinationOsteoarthritisRheumatologyInternal medicineOutcome Assessment Health CaremedicineHumansImmunology and AllergyMedical physicsSet (psychology)Modalitiesmedicine.diagnostic_testbusiness.industryArthritisReproducibility of Resultsmedicine.diseaseRheumatologyClinical trialPhysical therapybusinessThe Journal of Rheumatology
researchProduct

Spinal anaesthesia in a patient with post-spine surgery dural ectasia.

2013

Dural sac ectasia is a very infrequent anatomical abnormality, usually caused by connective tissue diseases, as Marfan syndrome. Very few cases have been described being a consequence of a previous spine surgical procedure. We describe the case of an elderly patient who should be operated on twice due to sub-occlusive colon disease. Surgery was performed under spinal anaesthesia. A dural sac ectasia was suspected after the first procedure and the abdominal X-ray was reviewed. The characteristics of the anatomical alteration and the course of both anaesthetic procedures were described. X-ray and CT images were provided.

musculoskeletal diseasesMarfan syndromeMalemedicine.medical_specialtymedicine.medical_treatmentDura materMegacolonPeritonitisCritical Care and Intensive Care MedicineAnesthesia SpinalFatal OutcomePostoperative ComplicationsEctasiaColostomySurgical Wound DehiscencemedicinePressureHumansColectomyInjections SpinalColectomyAbdomen AcuteAged 80 and overSigmoid DiseasesMegacolonbusiness.industryDural ectasiaColostomyLaminectomyLaminectomymedicine.diseaseBupivacaineCombined Modality TherapySurgeryAnti-Bacterial AgentsAnesthesiology and Pain Medicinemedicine.anatomical_structureDura MaterbusinessDilatation PathologicIntestinal VolvulusRevista espanola de anestesiologia y reanimacion
researchProduct

A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analy…

2018

Abstract Background Adalimumab and golimumab are effective in the treatment of moderate to severe ulcerative colitis. Aims We reported the comparative effectiveness of adalimumab and golimumab in ulcerative colitis. Methods 118 patients treated with adalimumab and 79 treated with golimumab were included and evaluated at 8 weeks and at the end of follow up. Results Overall clinical benefit was 72.6% at 8 weeks and 58.9% at the end of follow up. Patients with longer disease duration and those treated with adalimumab had a better outcome. Clinical benefit was 78.8% in adalimumab patients and 63.3% in golimumab patients (p = 0.026) after 8 weeks; it was 66.9% in adalimumab patients and 46.8% in…

musculoskeletal diseasesModerate to severeAdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaBiologicDisease durationAdalimumab; Biologics; Golimumab; Ulcerative colitis; Adalimumab; Adult; Antibodies Monoclonal; Colitis Ulcerative; Female; Humans; Italy; Logistic Models; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alphaUlcerativeBiologicsGolimumabSeverity of Illness IndexTreatment failureAntibodies03 medical and health sciences0302 clinical medicineInternal medicineMonoclonalAdalimumabmedicineHumansskin and connective tissue diseasesAdalimumab; Biologics; Golimumab; Ulcerative colitis; Hepatology; GastroenterologyPropensity ScoreProportional Hazards ModelsHepatologybusiness.industryTumor Necrosis Factor-alphaGastroenterologyAdalimumabAntibodies MonoclonalMiddle Agedmedicine.diseaseColitisUlcerative colitishumanitiesGolimumabLogistic ModelsTreatment OutcomeUlcerative colitisItaly030220 oncology & carcinogenesisPropensity score matching030211 gastroenterology & hepatologyColitis UlcerativeFemalebusinessmedicine.drug
researchProduct

Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders

2014

Abstract Tumor necrosis factor alpha (TNF-?) is an important pro-inflammatory cytokine associated with a variety of ocular diseases. The currently available TNF-? inhibitors are etanercept, infliximab, adalimumab, golimumab, and certolizumab. Experimental and clinical studies on the intravitreal use of these agents have been reported with etanercept, infliximab, and adalimumab: etanercept has shown limited efficacy in scarce reports; infliximab has been associated with local safety concerns but appears to benefit certain cases; adalimumab has shown no efficacy in cases of age-related macular degeneration (AMD) or diabetic macular edema (DME), but the combination with bevacizumab may be effe…

musculoskeletal diseasesOncologymedicine.medical_specialtyPathologygenetic structuresBevacizumabReviewCertolizumabEtanerceptEtanerceptIntravitreal injectionInternal medicineOcular disordersmedicineAdalimumabskin and connective tissue diseasesTumor necrosis factor alphabusiness.industryAdalimumabMacular degenerationmedicine.diseaseInfliximabeye diseasesGolimumabInfliximabOphthalmologyInfectious DiseasesTumor necrosis factor alphasense organsbusinessmedicine.drugJournal of Ophthalmic Inflammation and Infection
researchProduct

New Modalities in Knee Osteoarthritis Treatment Using Autologous Bone Marrow-Derived Mononuclear Cells

2018

Abstract The clinical effects on knee osteoarthritis (OA) symptoms and tissue structure were evaluated after bone marrow-derived mononuclear cell intraarticular injection. A group of 32 patients with 34 knee joints in stage II–III osteoarthritis were treated by intraarticular injection of mononuclear cell suspension. Clinical results were obtained by KOOS (Knee Osteoarthritis Outcome Score) and KSS (Knee Society Score) scores during a 12 months follow-up period. Radiological evaluation was performed using magnetic resonance imaging. A comparison with a control group of 28 patients treated with routinely used three hyaluronic acid intra-articular injections was made. No adverse effects were …

musculoskeletal diseasesPathologymedicine.medical_specialtymesenchymal stem cellsMultidisciplinaryModalitiesGeneral interestChemistryScienceQVirulenceOsteoarthritismedicine.disease_causeAutologous bonemedicine.diseasePeripheral blood mononuclear cellknee osteoarthritisMicrobiologyAntibiotic resistanceregenerative therapyhyaluronic acidmedicinebone marrow mononuclear cellsEscherichia coliGeneProceedings of the Latvian Academy of Sciences. Section B, Natural Sciences
researchProduct

Patients' conceptions of undergoing physiotherapy for persistent low back pain delivered in Finnish primary healthcare by physiotherapists who had pa…

2020

To explore the conceptions of patients with persistent low back pain (LBP) of undergoing physiotherapy delivered in Finnish primary healthcare by physiotherapists who had participated in brief training in Cognitive Functional Therapy (CFT).As part of a feasibility implementation study exploring CFT in management of LBP in the Finnish primary healthcare system, we interviewed nine patients from four geographical areas in Finland after receiving care. We used a phenomenographic approach to explore the variation in their conceptions.The analysis revealed four descriptive categories: "hung out to dry," "stuck," "making sense and taking control," and "holistic approach to care and living," that …

musculoskeletal diseasesmedicine.medical_specialtyPrimary Health Carebusiness.industryRehabilitationPrimary health careFunctional therapyCognitionLow back painPhysical TherapistsCognitionhealth services administrationmedicinePhysical therapypopulation characteristicsHumansmedicine.symptomPhenomenographybusinesshuman activitiesLow Back Painhealth care economics and organizationsFinlandPhysical Therapy ModalitiesDisability and rehabilitation
researchProduct

OP0015 Induction of remission and maintenance in early, aggressive rheumatoid arthritis using adalimumab in combination with methotrexate with or wit…

2017

Background Remission is the current aim of early RA treatment. In patients with early, aggressive RA, combination with adalimumab (ADA) plus methotrexate (MTX) was superior to either MTX or ADA alone in obtaining clinical remission. Moreover, it has been demonstrated that a short-term aggressive treatment with high-dose glucocorticoids (GC) plus conventional DMARDs lead to long-term (up to 5 years) benefits. Objectives To compare the proportion of patients who achieve remission at 12 months, between two groups of subjects treated with ADA + MTX + high dose GC (intensive) and ADA + MTX + placebo (standard), and to evaluate the proportion of those maintaining remission at 24 months, after dis…

musculoskeletal diseasesmedicine.medical_specialtybusiness.industry030503 health policy & servicesmedicine.diseasePlaceboGastroenterologyDiscontinuationFirst line treatmentDouble blind study03 medical and health sciences0302 clinical medicineimmune system diseasesPrednisoneRheumatoid arthritisInternal medicinemedicineAdalimumabMethotrexate030212 general & internal medicine0305 other medical sciencebusinessmedicine.drug
researchProduct

Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica.

2021

Glucocorticoids (GCs) are the mainstay of treatment for patients with polymyalgia rheumatica (PMR).1 Despite their efficacy, GCs are associated with well-known adverse events and a substantial proportion of patients with PMR do not respond adequately, or are refractory, to initial GC treatment. GC-sparing agents in PMR are limited to methotrexate (MTX).1.

musculoskeletal diseasesmedicine.medical_specialtyeducationImmunologyGiant Cell ArteritisPolymyalgia rheumaticaAbataceptDiagnosis DifferentialRheumatologyRefractoryimmune system diseasesInternal medicinemedicineImmunology and AllergyHumansskin and connective tissue diseasesAdverse effectbusiness.industryAbataceptmedicine.diseaseCombined Modality TherapyPolymyalgia RheumaticaMethotrexatebusinesshormones hormone substitutes and hormone antagonistsmedicine.drugThe Journal of rheumatology
researchProduct

Communicating through ancillary gestures: Exploring effects on coperformers and audiences

2020

Musicians make elaborate movements while performing, often using gestures that might seem extraneous. To explore these movements, we motion-captured and audio-recorded different pairings of clarinetists and pianists performing Brahms’ Clarinet Sonata No. 1 with two manipulations: (a) allowing the performers full vs. no visual feedback, and (b) allowing the performers full vs. partial auditory feedback (i.e., the clarinetist could not hear the pianist). We found that observer ratings of audio–visual point-light renditions discriminated between manipulations and refined this insight through subsequent audio-alone and visual-alone experiments, providing an understanding of each modality’s cont…

muusikotAuditory feedbackModality (human–computer interaction)Social Psychologyperformer cohesionCommunicationPerspective (graphical)point-light displaysVisual feedbackHuman-Computer Interactionancillary gestureExpression (architecture)music performanceeleetHuman–computer interactionexpressionAudience receptionPerforming artsmusiikkiesityksetPsychologyaudio-visualGestureHuman Technology
researchProduct